{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:45:12Z","timestamp":1758991512073,"version":"3.40.5"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To report treatment of vitreous seeding of choroidal melanoma with monthly injections of intravitreal melphalan.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Case report.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A 70-year-old white woman noted floaters in her left eye, and further examination revealed visual acuity of 20\/30 in both eyes. Funduscopically, there was a mushroom-shaped choroidal melanoma in her left eye, measuring 9 mm in basal dimension and 4.8 mm in thickness. Notably, there was apical retinal invasion of melanoma with mild vitreous hemorrhage, without vitreous seeding. The tumor was treated with iodine-125 plaque radiotherapy using an apex dose of 70 Gy over 99 hours, designed to include the retinal invasion. The melanoma demonstrated complete regression into a nearly flat scar of 1 mm and remained stable over 4 years. Five years after radiotherapy, there were diffuse vitreous pigmented seeds of presumed melanoma origin, emanating from the site of retinal necrosis. This progressively worsened over the following 18 months, suspicious for viable melanoma cells, as visual acuity concurrently declined to 20\/100. Treatment with intravitreal melphalan (10 <jats:italic toggle=\"yes\">\u03bc<\/jats:italic>g\/0.05 mL) was delivered on a monthly basis for 12 cycles, resulting in vitreous seeds regression, and preservation of the eye. Final visual acuity was 20\/200. There were no treatment-related complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Intravitreal melphalan can be considered in cases of vitreous seeding from uveal melanoma.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/icb.0000000000000798","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T01:14:28Z","timestamp":1532567668000},"page":"97-100","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["INTRAVITREAL MELPHALAN FOR TREATMENT OF VITREOUS SEEDING FROM CHOROIDAL MELANOMA"],"prefix":"10.1097","volume":"15","author":[{"given":"Babak","family":"Masoomian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arman","family":"Mashayekhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250507","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00006982-198808030-00008","article-title":"Choroidal malignant melanoma with early vitreous seeding","volume":"8","author":"Dunn","year":"1988","journal-title":"Retina"},{"key":"R2-20250507","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00006982-198200210-00006","article-title":"Pseudoretinitis pigmentosa secondary to preretinal malignant melanoma cells","volume":"2","author":"Eagle","year":"1982","journal-title":"Retina"},{"key":"R3-20250507","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0002-9394(98)00040-3","article-title":"Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study. COMS report no.6","volume":"125","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R4-20250507","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/bjophthalmol-2014-306443","article-title":"Suspected vitreous seeding of uveal melanoma: relevance of diagnostic vitrectomy","volume":"100","author":"Metz","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R5-20250507","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archopht.1997.01100150795018","article-title":"Intravitreal invasion of malignant cells from choroidal melanoma after brachytherapy","volume":"115","author":"Robertson","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R6-20250507","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archophthalmol.2007.50","article-title":"Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherapy in the collaborative ocular melanoma study","volume":"126","author":"Avery","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R7-20250507","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archopht.117.5.609","article-title":"Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma","volume":"117","author":"Gunduz","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R8-20250507","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archopht.117.6.771","article-title":"Choroidal melanomas with a collar-button configuration: response pattern after iodine 125 brachytherapy","volume":"117","author":"Robertson","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R9-20250507","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.survophthal.2013.01.003","article-title":"Local chemotherapeutic agents for the treatment of ocular malignancies","volume":"59","author":"Fernandes","year":"2014","journal-title":"Surv Ophthalmol"},{"key":"R10-20250507","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00270-017-1588-2","article-title":"Percutaneous isolated hepatic perfusion as a treatment for isolated hepatic metastases of uveal melanoma: patient outcome and safety in a multi-center study","volume":"40","author":"Vogl","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R11-20250507","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ophtha.2014.03.028","article-title":"Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study","volume":"121","author":"Francis","year":"2014","journal-title":"Ophthalmology"},{"key":"R12-20250507","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited, from prohibition to conditional indications","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R13-20250507","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamaophthalmol.2017.1810","article-title":"Intravitreal melphalan for treatment of primary vitreoretinal lymphoma: a new indication for an old drug","volume":"135","author":"Shields","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"R14-20250507","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archophthalmol.2012.1983","article-title":"Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma","volume":"130","author":"Ghassemi","year":"2012","journal-title":"Arch Ophthalmol"}],"container-title":["RETINAL Cases &amp; Brief Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICB.0000000000000798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T21:14:27Z","timestamp":1746652467000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICB.0000000000000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/icb.0000000000000798","relation":{},"ISSN":["1935-1089"],"issn-type":[{"type":"print","value":"1935-1089"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}